Market Pulse
Legal & General profits edge higher in cautious first half
Legal & General increased first-half profits by almost a quarter as strong growth from the annuity arm offset declines at investment management and insurance.
AstraZeneca drug fails in lung cancer trial
Pharmaceutical giant AstraZeneca announced results from the Phase III SELECT-1 trial of the MEK 1/2 inhibitor, selumetinib on Tuesday, in combination with docetaxel chemotherapy, as second-line treatment in patients with KRAS mutation-positive locally-advanced or metastatic non-small cell lung cancer.
London pre-open: Stocks seen touch higher ahead of data
Stocks in London were expected to open a little higher on Tuesday ahead of a slew of data releases.
Tuesday newspaper round-up: China warning, retailers, EDF threat, EU deal
China has issued its sternest warning yet to the UK that bilateral ties stand at a “crucial historical juncture” over London’s deferral of an £18bn nuclear power project. Liu Xiaoming, China’s ambassador to the UK, drew a clear link between Beijing’s desire to see an early go-ahead for the controversial Hinkley Point power project and the future of the UK-China relationship. - Financial Times.